Learn more about how you can help build a more equitable system for all
Protected: Tahir Amin
Bios and Intros
Biographies
Short (32 words)
Tahir Amin is the Chief Executive Officer of the Initiative for Medicines, Access & Knowledge (I-MAK), a nonprofit organisation working to address structural inequities in how medicines are developed and distributed.
Long (198 words)
Tahir Amin, LL.B., Dip. LP., is the Chief Executive Officer of the Initiative for Medicines, Access & Knowledge (I-MAK), a nonprofit organisation working to address structural inequities in how medicines are developed and distributed. He has over 25 years of experience in intellectual property (IP) law, during which he has practised with two of the leading IP law firms in the United Kingdom and served as IP Counsel for multinational corporations. His work focuses on re-shaping IP laws and the related global political economy to better serve the public interest, by changing the structural power dynamics that allow health and economic inequities to persist.
Amin and I-MAK have also put out a 10 point plan for the Biden-Harris administration to bring equity into the patent system, and their work is highlighted in the New York Times Editorial Board’s recent endorsement of patent reform. He is a former Harvard Medical School Fellow in the Department of Global Health & Social Medicine and TED Fellow. Amin has served as legal advisor/consultant to many international groups, including the European Patent Office and World Health Organization, and has testified before the U.S. Congress on intellectual property and unsustainable drug prices.
Headshots & Photos
Click to download
Promo
https://www.youtube.com/watch?v=tBSFyw-CDyQ
Vice speaks with Tahir Amin on why America's role in putting off waiving the intellectual property on Covid-19 vaccines prevents other countries from being able to get health workers and the elderly vaccinated and how that is effectively raising the global death toll.